Regulatory strategy consulting firms are operating in one of the most complex agency environments in recent history. The FDA's evolving approach to accelerated approval pathways, the EU's new pharmaceutical legislation reshaping EMA procedures, and the global expansion of joint HTA initiatives have created a regulatory landscape that demands sophisticated strategic counsel — and extensive operational coordination to navigate effectively. For consulting firms advising pharma and biotech clients across multiple regulatory programs, the administrative overhead of billing management, client account coordination, and agency interaction logistics is consuming hours that senior regulatory strategists cannot spare.
Virtual assistants are enabling regulatory strategy consulting firms to manage this administrative layer efficiently, freeing regulatory experts to focus on the agency strategy work that determines client success.
Billing Tied to Regulatory Program Milestones
Regulatory strategy consulting billing is tightly linked to program milestones. Engagements organized around FDA Breakthrough Therapy Designation applications, Type B pre-NDA meetings, EMA Scientific Advice procedures, or 505(b)(2) strategy packages each carry distinct deliverable structures and billing timelines. Managing invoice preparation across these milestones — tracking deliverable completion, coordinating sponsor purchase order requirements, managing change-order documentation when regulatory programs evolve — requires systematic administrative attention.
The FDA reports that the average drug development program involves more than 25 formal FDA interactions from IND to NDA filing. Each interaction represents a potential billing event for the regulatory strategy firm supporting that program. For firms managing multiple client programs simultaneously, the billing coordination workload is substantial.
Virtual assistants can manage milestone invoice preparation, track deliverable completion against contracted billing triggers, coordinate sponsor billing portal submissions, and maintain accounts receivable schedules — reducing payment lag and freeing regulatory staff from billing administration.
Client Account Management Across Pharma and Biotech Relationships
Regulatory strategy consulting clients span the full spectrum of pharma and biotech development stages, from early-stage biotechs navigating their first IND submissions to established manufacturers managing complex post-approval variation procedures. Each client relationship requires tailored account administration — onboarding documentation workflows, communication cadence setup, and ongoing coordination support calibrated to their regulatory program stage.
New client onboarding involves collecting development program briefings, establishing secure document-sharing protocols for regulatory dossier materials, configuring project management systems with appropriate sponsor access, and documenting initial regulatory strategy assumptions for alignment. Virtual assistants can manage this onboarding workflow, ensuring clients are properly integrated before strategic engagement begins.
Ongoing account administration includes maintaining regulatory program calendars, distributing agency guidance updates relevant to active client programs, coordinating review and approval workflows for strategy memoranda and position papers, and preparing logistics packages for client review calls. According to McKinsey's 2024 Biopharma Regulatory Excellence Report, clients consistently identify organized communication and consistent documentation as top drivers of satisfaction with external regulatory strategy partners.
FDA and EMA Agency Coordination Support
Agency interaction management is at the core of regulatory strategy consulting. FDA meeting requests — Type A, B, and C meeting submissions — require formal request packages, pre-meeting briefing document preparation, and careful follow-up tracking against PDUFA-defined response timelines. EMA Scientific Advice procedures involve submission of questions-and-answers documents, procedure timeline management, and coordination with EMA project managers. These coordination activities are dense, deadline-driven, and carry high stakes.
Virtual assistants can manage the logistics around agency interactions: preparing meeting request packages from strategist-provided content, tracking FDA response timeline milestones, organizing EMA procedure calendars, distributing agency responses to client teams, and maintaining organized archives of all agency correspondence. According to FDA CDER's 2025 Meeting Management Guidance, firms that manage FDA meeting logistics with systematic documentation and follow-up demonstrate significantly better meeting preparation quality.
Deloitte's 2025 Regulatory Affairs Efficiency Report found that regulatory consulting firms with structured agency interaction coordination support completed FDA meeting cycles an average of 14 days faster than those relying on ad hoc coordination by strategists.
Scaling Regulatory Consulting Operations
Regulatory strategy consulting firms are competing for pharma and biotech client relationships on the basis of scientific and regulatory expertise. Every hour a senior regulatory strategist spends on billing reconciliation, meeting logistics, or document distribution is an hour not spent on the strategic counsel that wins and retains clients. Virtual assistants restore that focus — expanding firm capacity to serve more clients without proportionally expanding expert headcount.
Regulatory strategy consulting firms ready to reduce billing overhead, systematize FDA and EMA coordination, and improve client account management should explore what Stealth Agents delivers for life sciences professional services environments.
Sources
- FDA CDER, Meeting Management Guidance for Drug Development Programs, 2025
- McKinsey & Company, Biopharma Regulatory Excellence Report, 2024
- Deloitte, Regulatory Affairs Efficiency Report, 2025